WallStSmart

GE HealthCare Technologies Inc. (GEHC)vsKoninklijke Philips NV ADR (PHG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

GE HealthCare Technologies Inc. generates 16% more annual revenue ($20.63B vs $17.83B). GEHC leads profitability with a 10.1% profit margin vs 5.0%. PHG appears more attractively valued with a PEG of 0.36. GEHC earns a higher WallStSmart Score of 60/100 (C+).

GEHC

Buy

60

out of 100

Grade: C+

Growth: 4.0Profit: 7.0Value: 7.3Quality: 4.3
Piotroski: 2/9Altman Z: 1.34

PHG

Hold

49

out of 100

Grade: D+

Growth: 5.3Profit: 5.0Value: 7.3Quality: 5.3
Piotroski: 6/9Altman Z: 1.47
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

GEHCSignificantly Overvalued (-151.0%)

Margin of Safety

-151.0%

Fair Value

$31.55

Current Price

$69.65

$38.10 premium

UndervaluedFair: $31.55Overvalued
PHGSignificantly Overvalued (-340.5%)

Margin of Safety

-340.5%

Fair Value

$7.28

Current Price

$26.25

$18.97 premium

UndervaluedFair: $7.28Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GEHC2 strengths · Avg: 8.5/10
Return on EquityProfitability
22.4%9/10

Every $100 of equity generates 22 in profit

P/E RatioValuation
15.6x8/10

Attractively priced relative to earnings

PHG4 strengths · Avg: 9.0/10
PEG RatioValuation
0.3610/10

Growing faster than its price suggests

Revenue GrowthGrowth
110.0%10/10

Revenue surging 110.0% year-over-year

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$1.31B8/10

Generating 1.3B in free cash flow

Areas to Watch

GEHC4 concerns · Avg: 2.8/10
PEG RatioValuation
1.724/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

EPS GrowthGrowth
-17.7%2/10

Earnings declined 17.7%

Altman Z-ScoreHealth
1.342/10

Distress zone — elevated risk

PHG4 concerns · Avg: 3.0/10
P/E RatioValuation
26.4x4/10

Moderate valuation

Return on EquityProfitability
7.8%3/10

ROE of 7.8% — below average capital efficiency

Profit MarginProfitability
5.0%3/10

5.0% margin — thin

EPS GrowthGrowth
-50.0%2/10

Earnings declined 50.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : GEHC

The strongest argument for GEHC centers on Return on Equity, P/E Ratio.

Bull Case : PHG

The strongest argument for PHG centers on PEG Ratio, Revenue Growth, Price/Book. Revenue growth of 110.0% demonstrates continued momentum. PEG of 0.36 suggests the stock is reasonably priced for its growth.

Bear Case : GEHC

The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, EPS Growth.

Bear Case : PHG

The primary concerns for PHG are P/E Ratio, Return on Equity, Profit Margin.

Key Dynamics to Monitor

GEHC profiles as a value stock while PHG is a hypergrowth play — different risk/reward profiles.

GEHC carries more volatility with a beta of 1.18 — expect wider price swings.

PHG is growing revenue faster at 110.0% — sustainability is the question.

PHG generates stronger free cash flow (1.3B), providing more financial flexibility.

Bottom Line

GEHC scores higher overall (60/100 vs 49/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

GE HealthCare Technologies Inc.

HEALTHCARE · MEDICAL DEVICES · USA

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

Koninklijke Philips NV ADR

HEALTHCARE · MEDICAL DEVICES · USA

Koninklijke Philips NV is a healthcare technology company in North America, Greater China and internationally. The company is headquartered in Amsterdam, the Netherlands.

Want to dig deeper into these stocks?